Used in research and diagnostic applications targeting amyloid-beta (Aβ) peptides associated with Alzheimer’s disease. This antibody specifically binds to amyloid-beta aggregates, enabling detection and quantification in biological samples such as cerebrospinal fluid and brain tissue. It is employed in immunoassays, immunohistochemistry, and imaging studies to study plaque formation and monitor disease progression. Due to its single-chain fragment (scFv) format, it offers improved tissue penetration and is suitable for engineering into therapeutic constructs or biosensors. Also used as a reference standard in preclinical studies to evaluate the efficacy of anti-amyloid therapies.